# Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia

> **NCT00127387** · PHASE2,PHASE3 · TERMINATED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 54 (estimated)

## Conditions studied

- Lung Cancer
- Prostate Cancer
- Neoplasm Metastasis
- Bone Cancer

## Interventions

- **DRUG:** Enbrel

## Key facts

- **NCT ID:** NCT00127387
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-05
- **Primary completion:** 2005-09
- **Final completion:** 2005-11
- **Target enrollment:** 54 (ESTIMATED)
- **Why stopped:** PI moved to Oregon
- **Last updated:** 2012-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00127387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00127387, "Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00127387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*